Test Price
2,800 AED✅ Home Collection Available
NOTCH1 Gene Aortic Valve Disease Type 1 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NOTCH1 لمرض الصمام الأبهري من النوع 1 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Gold‑standard, DHA‑compliant next‑generation sequencing for NOTCH1‑related aortic valve disease. Delivered with VIP home collection, academic‑level clinical interpretation, and direct insurance support.
ملخص تنفيذي: يوفر هذا الاختبار الجيني المتطور تسلسلاً شاملاً لجين NOTCH1 للكشف عن الطفرات المسببة لمرض الصمام الأبهري من النوع 1، بدقة تشخيصية تصل إلى 99.9%.
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- ✔ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain & VIP Mobile Phlebotomy.
- ✔ Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by a DHA‑licensed physician.
- ✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The NOTCH1 NGS test is a definitive genetic analysis for Aortic Valve Disease type 1 (AOVD1), confirming pathogenic variants in the NOTCH1 gene – essential for risk stratification, family screening, and surgical planning. يُعد هذا التحليل الجيني الشامل المرجع الأكاديمي لتشخيص مرض الصمام الأبهري من النوع 1 وتقييم المخاطر العائلية بدقة فائقة.
| Feature | Our Test (NOTCH1 NGS) | Closest Alternative |
|---|---|---|
| Precision | Full coding & splice‑site coverage; variant detection ≥99.9% | Limited to known hot‑spots; may miss novel mutations |
| Method | Next‑Generation Sequencing (NGS) with Sanger validation | Sanger sequencing of selected exons |
| Speed | 3–4 Weeks | 5–6 Weeks (if multiple exons tested individually) |
| Clinical Interpretation | Board‑certified geneticist + cardiologist review | Automated variant calling, limited counseling |
*Comparisons based on publicly available laboratory protocols, استنادًا إلى بروتوكولات المختبرات المعتمدة.
Physician Insight & Safety Protocol
“As the interpreting cardiologist, I understand the emotional weight of genetic testing for aortic valve disease. This analysis delivers objective, actionable information to guide your cardiovascular care and family planning, but it must be viewed alongside your echocardiogram and clinical history.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011, Consultant Cardiologist
⚠ Medication Warning:
Do not discontinue any prescribed medication (anticoagulants, antihypertensives, etc.) without consulting your doctor.
Safety Exclusion & Red Flags
- Exclusion Criteria: Not suitable for patients experiencing acute myocardial infarction, decompensated heart failure, or those unable to give informed consent.
- Emergency Red Flags: New‑onset crushing chest pain, fainting (syncope), severe shortness of breath, or palpitations – seek immediate emergency room care.
- Pediatric Notice: For minors, testing is conducted only with legal guardian consent and in accordance with UAE CDS Law 2026.
Patient FAQ & Clinical Guidance
Q1: What does the NOTCH1 gene test detect?
ماذا يكشف اختبار جين NOTCH1؟ The NOTCH1 Genetic Test comprehensively sequences the entire coding region and splice sites of the NOTCH1 gene to detect pathogenic variants linked to Aortic Valve Disease type 1. This enables precise diagnosis, identification of at‑risk family members, and preoperative risk stratification.
Q2: How is the sample collected and how long until results?
كيف يتم جمع العينة وكم تستغرق النتائج؟ A trained phlebotomist collects a single blood sample (or one‑drop FTA card) at your home or office using ISO‑certified cold‑chain protocols. Results are available in 3–4 weeks, delivered through a secure teleconsultation with a DHA‑licensed genetic counselor.
Q3: Who should consider this?
من هم المرشحون المثاليون لهذا الاختبار؟ Individuals with a personal or family history of bicuspid aortic valve, early‑onset aortic stenosis or regurgitation, or those planning cardiac surgery benefit most. It is also recommended for first‑degree relatives of a confirmed NOTCH1 mutation carrier to clarify lifelong risk and surveillance needs.
UAE Regulatory & Data Privacy Compliance
- Operated under Federal Decree‑Law No. 41 of 2024, Article 87 – genetic testing and informed consent protocols.
- Fully aligned with UAE Child Data Security (CDS) Law 2026 for minors’ genetic data.
- All personal health information is protected per UAE PDPL (Personal Data Protection Law).
- ISO 9001:2015 Certified Facility – Cert: INT/EGQ/2509DA/3139. Facility License: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians